Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol vs Sevoflurane for Emergence Agitation in Laparoscopic Surgery
NCT05624424Phase 4Unknown
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Nov 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam in general anesthesia (3 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: The incidence of emergence agitation. Status: unknown.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT05624424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05624424.